Santa Barbara City College president steps down
Note: This article was updated to include information about Goswami’s severance pay. Utpal Goswami resigned as superintendent and president of Santa Barbara City College on July 12, just over a year and a half into his term. SBCC announced Goswami’s resignation after a special Board of Trustees meeting on July 12, during which the board Read More →
Real Estate: Simi Valley industrial property sold for $20M
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
30 years of South Coast Deli: Santa Barbara tech scene boosts local sandwich shop
When Jim St. John launched South Coast Deli in Carpinteria 30 years ago, his goal was to bring an edgier menu to the region and as a result, he added a scoop of culinary innovation to an emerging technology hub. Basil mayo, cranberry-thyme cream cheese and a killer garlic dressing for Caesar sandwiches struck a Read More →
A century of Central Coast health
Despite vaccines, a drop in infectious rates and cities shifting from protective health measures to preventative approaches, 2021 resumes the two-year trend of health care as a focal issue in the U.S., as cities direct what they hope to be the COVID’s third and final act. With hospitals and clinics already in their communities’ spotlight, Read More →
Westlake Village card processing company agrees to $2 million-plus settlement with DA’s office
The Ventura County District Attorney’s Office announced July 9 that it has settled a civil law enforcement action against Westlake Village-based Leaders Merchant Services. The complaint alleged that Leaders violated California laws against unfair competition and misleading advertising when Leaders’ sales personnel didn’t fully disclose the company’s fees while signing customers up for payment card Read More →
FDA gives Amgen priority review for asthma treatment
Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →
Dubroff: Infrastructure, tax reform gain momentum in Washington
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
